Potential of Curcuma amada in Cancer Therapy: A Phytochemical Perspective
Authors
School of Pharmacy and Research, Dev Bhoomi Uttarakhand University, Dehradun, Uttarakhand (India)
School of Pharmacy and Research, Dev Bhoomi Uttarakhand University, Dehradun, Uttarakhand (India)
School of Pharmacy and Research, Dev Bhoomi Uttarakhand University, Dehradun, Uttarakhand (India)
School of Pharmacy and Research, Dev Bhoomi Uttarakhand University, Dehradun, Uttarakhand (India)
School of Pharmacy and Research, Dev Bhoomi Uttarakhand University, Dehradun, Uttarakhand (India)
School of Medical & Allied Sciences, K.R. Mangalam University, Gurugram, Haryana (India)
School of Pharmacy and Research, Dev Bhoomi Uttarakhand University, Dehradun, Uttarakhand (India)
Article Information
DOI: 10.51244/IJRSI.2026.1306000208
Subject Category: Cancer Pharmacology
Volume/Issue: 13/6 | Page No: 2919-2934
Publication Timeline
Submitted: 2026-06-30
Accepted: 2026-06-30
Published: 2026-06-30
Abstract
Medicinal plants are being used for therapeutic purposes since the human civilization. The efficacy of these medicinal plants is due to presence of broad range of phytochemical constituents present. Curcuma amada is very common herb belong to family Zingiberaceae and is used as spice in different regions of the world and also serves as a home remedy for treating different diseases. Curcuma amada is widely evaluated for its anticancer activity. The major constituents found in its rhizomes are Curcuminoids (Curcumin), Phenolic compounds, terpenoids and essential oils. The primary phytoconstituents Curcumin is responsible for its various therapeutic properties. Curcumin possesses broad remedial potential due to its multi targeting effect against many different carcinomas including Leukemia, breast cancer etc. Hence, Curcumin can treat several diseases because of its potential for the development of new medicine
Keywords
Curcuma amada, Curcumin, Phytoconstituents, Curcuminoids, Anti-cancer
Downloads
References
1. Tyagi BB, Bhardwaj NK, Raina V. Time trends of cancer in a tertiary care centre 2013–2017. Int J Med Health Res 2019;5 (11):152–158. [Google Scholar] [Crossref]
2. Sadanandam, Vemula & Dhakshanamoorthy, Kalpanapriya. (2025). Epidemiology of Cancer Incidence Estimates and Statistics 2000–2025: Analysis from National Cancer Registry Programme in India. Indian Journal of Medical and Paediatric Oncology. 46. 10.1055/s-0044-1801767. [Google Scholar] [Crossref]
3. Office of the Registrar General & Census Commissioner India.Census of India Website. Censusindia.gov.in. Published 2011 at: http://www.censusindia.gov.in/census.website [Google Scholar] [Crossref]
4. Babu GR, Lakshmi SB, Thiyagarajan JA. Epidemiological correlates of breast cancer in South India. Asian Pac J Cancer Prev 2013;14(09):5077–5083 [Google Scholar] [Crossref]
5. Thangjam S, Laishram RS, Debnath K. Breast carcinoma in young females below the age of 40 years: a histopathological perspective. South Asian J Cancer 2014;3(02):97–100 [Google Scholar] [Crossref]
6. Jonnada PK,Sushma C, Karyampudi M, Dharanikota A. Prevalence of molecular subtypes of breast cancer in India: a systematic review and meta-analysis. Indian J Surg Oncol 2021;12(Suppl 1):152–163 [Google Scholar] [Crossref]
7. Ali I, Wani WA, Saleem K. Cancer scenario in India with future perspectives. Cancer Ther 2011; 8:56–70 [Google Scholar] [Crossref]
8. Srinath Reddy K, Shah B, Varghese C, Ramadoss A. Responding to the threat of chronic diseases in India. Lancet 2005;366(9498):1744–1749 [Google Scholar] [Crossref]
9. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA: A Cancer J Clin, 2019; 69(1):7–34. Available via http://doi.wiley. com/10.3322/caac.21551 [Google Scholar] [Crossref]
10. Global Cancer Burden Growing, Amidst Mounting Need for Services. Available online: https://www.who.int/news/item/01-02-2024-global-cancer-burden-growing--amidst-mounting -need-for-services#:~:text=In%202022,%20there%20were%20an, women% 20die% 20from% 20the%20disease (accessed on 01 May 2026). [Google Scholar] [Crossref]
11. Ferlay, J.; Soerjomataram, I.; Dikshit, R.; Eser, S.; Mathers, C.; Rebelo, M.; Parkin, D.M.; Forman, D.; Bray, F. Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in GLOBOCAN 2012. Intl J. Cancer 2015, 136, E359–E386. [Google Scholar] [Crossref]
12. Jain, S.; Rachamalla, M.; Kulkarni, A.; Kaur, J.; Tikoo, K. Pulmonary Fibrotic Response to Inhalation of ZnO Nanoparticles and Toluene Co-Exposure through Directed Flow Nose Only Exposure Chamber. Inhal. Toxicol. 2013, 25, 703–713. [Google Scholar] [Crossref]
13. Chauthe, S.K.; Mahajan, S.; Rachamalla, M.; Tikoo, K.; Singh, I.P. Synthesis and Evaluation of Linear Furanocoumarins as Potential Anti-Breast and Anti-Prostate Cancer Agents. Med. Chem. Res. 2014, 24, 2476–2484. [Google Scholar] [Crossref]
14. Mukherjee, S.; Patra, C.R. Therapeutic Application of Anti-Angiogenic Nanomaterials in Cancers. Nanoscale 2016, 8, 12444–12470. [Google Scholar] [Crossref]
15. Patra, C.R.; Mukherjee, S.; Kotcherlakota, R. Biosynthesized Silver Nanoparticles: A Step Forward for Cancer Theranostics? Nanomedicine 2014, 9, 1445–1448. [CrossRef] [Google Scholar] [Crossref]
16. Ijaz, S.; Akhtar, N.; Khan, M.S.; Hameed, A.; Irfan, M.; Arshad, M.A.; Ali, S.; Asrar, M. Plant Derived Anticancer Agents: A Green Approach towards Skin Cancers. Biomed. Pharmacother. 2018, 103, 1643–1651. [Google Scholar] [Crossref]
17. Peyromaure, M. et al. Management of prostate cancer in china: a multicenter report of 6 institutions. J. Urol. 174 (5), 1794–1797 (2005). [Google Scholar] [Crossref]
18. Yin, S. Y., Wei, W. C., Jian, F. Y. & Yang, N. S. Therapeutic applications of herbal medicines for cancer patients. Evid. Based Complement. Alternat. Med. 2013, 302426 (2013). [Google Scholar] [Crossref]
19. Liu, Z. L. et al. Traditional Chinese medicinal herbs combined with epidermal growth factor receptor tyrosine kinase inhibitor for advanced non-small cell lung cancer: a systematic review and meta-analysis. J. Integr. Med. 12 (4), 346–358 (2014). [Google Scholar] [Crossref]
20. Fu, B. et al. Multi-component herbal products in the prevention and treatment of chemotherapy-associated toxicity and side effects: a review on experimental and clinical evidences. Front. Pharmacol. 9, 1394 (2018). [Google Scholar] [Crossref]
21. Wang, Z. et al. An update on Chinese herbal medicines as adjuvant treatment of anticancer therapeutics. Biosci. Trends. 12 (3), 220–239 (2018). [Google Scholar] [Crossref]
22. Zhang, X., Qiu, H., Li, C., Cai, P. & Qi, F. The positive role of traditional Chinese medicine as an adjunctive therapy for cancer. Biosci. Trends. 15 (5), 283–298 (2021). [Google Scholar] [Crossref]
23. Tamta, A.; Prakash, O.; Punetha, H. and Pant, A.K. (2016). Chemical composition and in vitro antioxidant potential of essential oil and rhizome extracts of Curcuma amada Roxb. Cogent Chemistry, 2(1): 1168067. [Google Scholar] [Crossref]
24. Akter, J.; Takara, K.; Islam, M.J.; Hossain, M.A.; Sano, A. and Hou, D. (2019). Isolation and structural elucidation of antifungal compounds from Curcuma amada. Asian Pacific Journal of Tropical Medicine, 12(3): 123-129. [Google Scholar] [Crossref]
25. Tamara S. Al-Qudah1, Saida Abu Malloh1, Aamir Nawaz2, Muhammad Adnan Ayub2, Shafaq Nisar2*, Muhammad Idrees Jilani2 and Tamadour Said Al-Qudah3 , Mango ginger (Curcuma amada Roxb.): A phytochemical mini review , International Journal of Chemical and Biochemical Sciences. 2017) ; 51-57 [Google Scholar] [Crossref]
26. Chen, Y., Shukurova, M. K., Asikin, Y., Kusano, M. & Watanabe, K. N. Characterization of volatile organic compounds in Mango ginger (Curcuma amadaRoxb.) from Myanmar. Metabolites 11 (1), 21 (2020). [Google Scholar] [Crossref]
27. Lalit R. Samant*, Curcuma amada Roxb.: A Phytopharmacological Review, Journal of Pharmacy Research Vol.5 Issue 4. April 2012 ; 5(4);1992-93. [Google Scholar] [Crossref]
28. S. Syamkumar, B. Sasikumar. (2007). Molecular marker based genetic diversity analysis of Curcuma species from India. Scientia Horticulturae. 112(2): 235-241. [Google Scholar] [Crossref]
29. Al-Qudah, T. S., Malloh, S. A., Nawaz, A., Ayub, M. A., Nisar, S., Jilani, M. I., & Al-Qudah, T. S. (2017). Mango ginger (Curcuma amada Roxb.): A phytochemical mini review. Ijcbs, 11, 51-57. [Google Scholar] [Crossref]
30. M.A. Hanif, M.Y. Al-Maskari, A. Al-Maskari, A. Al-Shukaili, A.Y. Al-Maskari, J.N. Al-Sabahi. (2011). Essential oil composition, antimicrobial and antioxidant activities of unexplored Omani basil. Journal of Medicinal Plants Research. 5(5): 751-757. [Google Scholar] [Crossref]
31. Lakshminarayana S, Siddappa GS, SubbaRao MS and Johar DS 1963 Preservation of mango ginger. Food Sci. 12 11–14 [Google Scholar] [Crossref]
32. Dutt S and Tayal JN 1941 Chemical examination of the essential oil derived from the rhizomes of Curcuma amada Roxb. Ind. Soap J. 7 200–205 [Google Scholar] [Crossref]
33. Golap SG and Bandyopadhyaya C 1984 Characterization of mango-like aroma in Curcuma amada Roxb. J. Agric. Food Chem. 32 57–59 [Google Scholar] [Crossref]
34. Rao AS, Rajanikanth B and Seshadri R 1989 Volatile aroma components of Curcuma amada Roxb. J. Agric. Food Chem. 37 740–743 [Google Scholar] [Crossref]
35. Choudhury SN, Rabha LC, Kanjilal PB, Ghosh AC and Leclercq PA 1996 Essential oil of Curcuma amada Roxb. from northeastern India. J. Ess. Oil Res. 8 79–80 [Google Scholar] [Crossref]
36. Mustafa A, Ali M and Khan ZN 2005 Volatile oil constituents of the fresh rhizomes of Curcuma amada Roxb. J. Ess. Oil Res. 17 490–491 [Google Scholar] [Crossref]
37. Srivastava AK, Srivastava SK and Shah NC 2001 Constituents of the rhizome essential oil of Curcuma amada Roxb. from India. J. Ess. Oil Res. 13 63–64 [Google Scholar] [Crossref]
38. Bandyopadhyay C. 1993. Recent trends in flavor evaluation of spices. In International Symposium on Newer Trends Essential Oils Flavor, Dhar KL, Thappa RK, Agarwal SG (eds). Tata McGraw-Hill: New Delhi, 153–173. [Google Scholar] [Crossref]
39. Barman PD, Rajasree V, Mohanalakshmi M, Renuka R, Meenakshi P. Phytochemical profiling of Mango ginger (Curcuma amada): A comprehensive review of bioactive compounds and health implications. Plant Science Today.2024;11(sp4):01-14. https:/doi.org/10.14719/pst.5622 [Google Scholar] [Crossref]
40. Akter J, Islam MZ, Hossain MA, Takara K. (2021) Anti-tyrosinase properties of different species of turmeric and isolation of active compounds from Curcuma amada. Medicinal Chemistry Research,) 30(6)1669–1676 [Google Scholar] [Crossref]
41. Naskar C, Halder S, Ghosh A. Evaluation of cytotoxic activity of the crude extract of Curcuma amada Roxb. Int J Res Anal Rev. 2018; 5(2): 913-15. [Google Scholar] [Crossref]
42. Sivaprabha J , Dharani, B ,Padma P.R & Sumathi S..(2015) Induction of DNA damage by the leaves and rhizomes of Curcuma amada Roxb in breast cancer cell lines.Journal of Acute Disease,4(1),12-17 [Google Scholar] [Crossref]
43. Donipati P, Sreeramulu S.H,Donipati P.J, Yugandhar N.M .(2022) .Invitro Anticancer Activity Of Curcuma Amada against Human Breast Cancer Cell Line Mcf-7.NeuroQuantalogy,20(20),2857-2879. [Google Scholar] [Crossref]
44. Sivaprabha J , Dharani, B ,Padma P.R & Sumathi S.(2016).Apoptosis-induced in vitro anticancer activity of methanolic extract of leaves and rhizomes of Curcuma amada Roxb. against breast cancer cells. International Journal of Green Pharmacy ,10(2),99-103. [Google Scholar] [Crossref]
45. Priyadarshini A, Mohanty D, Mohanty S, kerry R .G , Sahoo A,Dash B, Panda P.C, Nayak S , Ray A, Jena S.(2025).Unveiling the anticancer potential of Curcuma amada rhizome extract against prostate cancer through computational and experimental approaches.Scientific Reports ,15,24739 [Google Scholar] [Crossref]
46. Dondapati M, Reyes J.V.M, Ahmed S, Stern AS, Lieber JJ. (2021). Rare Adult Subtype of Rhabdomyosarcoma, a Common Childhood Soft Tissue Carcinom. Journal of Investigative Medicine High Impact Case Reports Volume 9: 1–4 [Google Scholar] [Crossref]
47. Ramachandran C, Lollett IV ,Escalon E, Quirin K.W, Melnick S.J.(2015) .Therapeutic Effect of Supercritical CO2 Extracts of Curcuma Species with Cancer Drugs in Rhabdomyosarcoma Cell Lines. Phototherapy Research ,29, 1152-1160 [Google Scholar] [Crossref]
48. Davis ME.(2016) Glioblastoma: Overview of Disease and Treatment. Clinical Journal of Oncology Nursing, 20(5 suppl), S2-S8. [Google Scholar] [Crossref]
49. Ramachandran C, Lollett IV, Escalon E, Quirin K. W, Melnick S.J.(2015). Anticancer Potential and Mechanism of Action of Mango Ginger (Curcuma amadARoxb.) Supercritical CO2 Extract in Human Glioblastoma Cells. Journal of Evidence-Based Complementary & Alternative Medicine,20(2), 109-119 [Google Scholar] [Crossref]
50. Ramachandran C, Juan A , Quirin K .W, Khatib L, Escalon E, Khatib Z, and Melnick S. J.(2018).Anti cancer and Anti -metastatic E ffects of Supercriti cal E xtracts of Hops ( Humulus lupulus L.) and M ango ginger ( Curcum aamada Roxb.) in H uman G lioblastoma. International journal of phytomedicine, 10(4),191-200 [Google Scholar] [Crossref]
51. Ramachandran C, Lollett IV ,Escalon E, Quirin K.W, Melnick S.J. .(2017)In Vivo Antitumor Effect of Supercritical CO2 Extract of Mango Ginger (Curcuma amada Roxb) in U-87MG Human GlioblastomaNude Mice Xenografts.Journal of Evidence-Based Complementary & Alternative Medicine ,22(2) ,260-267 [Google Scholar] [Crossref]
52. World Health Organization. (2023, June 26). Lung cancer. https://www.who.int/news-room/fact-sheets/detail/lung-cancer (Accessed on 01 May 2026) [Google Scholar] [Crossref]
53. Policegoudra RS , Chandrashekhar RH, Aradhya SM, Singh l.(2011). Cytotoxicity, Platelet Aggregation Inhibitory and Antioxidant Activity of Curcuma amada Roxb. Extracts. Food and Chemical Toxicology.,49(2),162-168 [Google Scholar] [Crossref]
54. https://www.researchgate.net/publication/279529866_Anticancer_and_antioxidant_activity_ofCurcuma_zedoaria_and_Curcuma_amada_rhizome_extracts [Google Scholar] [Crossref]
55. https://doi.org/10.1016/j.cpt.2024.08.002 [Google Scholar] [Crossref]
56. Akter J, Islam MZ, Hossain MA, Takara K. (2021) Anti-tyrosinase properties of different species of turmeric and isolation of active compounds from Curcuma amada. Medicinal Chemistry Research,) 30(6)1669–1676 [Google Scholar] [Crossref]
57. World Health Organization. (2025 December 2).Cervical cancer. https://www.who.int/news-room/fact-sheets/detail/cervical-cancer. (Accessed on 01 May 2026) [Google Scholar] [Crossref]
58. Palanisamy VD, Samiappan S,(2017). Antioxidant and chemotherapeutic potential of curcuma amada rhizome extract on benzo(a)pyrene induced cervical carcinoma in sprague dawley rats. Asian journal of pharmaceutical and clinical research . 10(3), 235-242 [Google Scholar] [Crossref]
59. Tariq AL .(2016). Preliminary Phytochemical Screening and Anti angiogenesis Studies of Different Extracts of Curcuma amada . International Journal of Current Microbiology and Applied Sciences. 5(10),109-11 [Google Scholar] [Crossref]
60. Prema D, Kamaraj M, Achiraman S, Udayakumar R.(2014). In vitro antioxidant and cytotoxicity studies of Curcuma amada Roxb. (Mango ginger). International Journal of Scientific and Research Publications,4(4),1-6 [Google Scholar] [Crossref]
61. Watanabe, K., Gilani, S., Kikuchi, A., & Jatoi, S. (2007). Phytochemical, Pharmacological and Ethnobotanical Studies in Mango Ginger (Curcuma amada Roxb.; Zingiberaceae). Phytotherapy Research, 21(6), 507–516. https://doi.org/10.1002/ptr.2137 [Google Scholar] [Crossref]
62. Kirtikar K R and Basu B D. Indian medicinal plants Vol. 4, second edition (Dehra Dun: Bishen Singh Mahendra Pal Singh) 1984; pp. 2422-2423. [Google Scholar] [Crossref]
63. Hussain A, Virmani O P, Popli S P, Misra L N and Gupta M M. Dictionary of Indian Medicinal Plants. Central Institute of Medicinal Plants and Aromatic Plants. Lucknow 199; 2:39. [Google Scholar] [Crossref]
64. Warrier P K, Nambiar V P K and Ramankutty C. Indian medicinal plants—a compendium of 500 species, Chennai: Orient Longman Pvt. Ltd, vol. 1 p. 106; 1994 [Google Scholar] [Crossref]